非酒精性脂肪性肝炎 (NASH)通常合并胰岛素抵抗(IR) ,观察胰岛素敏感性对NASH肝组织学特征的影响有助于判断IR能否导致NASH。胰岛素增敏剂曲格列酮因其肝毒性而退出市场。与其同属噻唑烷二酮类的罗格列酮能否替代用于NASH的治疗引人关注。为此 ,此研究通过非随机开放试验评估罗 Non-alcoholic steatohepatitis (NASH) is usually associated with insulin resistance (IR). Observing the effect of insulin sensitivity on the histological features of NASH can help determine whether IR contributes to NASH. Insulin sensitizer troglitazone withdraws from the market due to its hepatotoxicity. Whether or not rosiglitazone, which belongs to the same thiazolidinediones, can be substituted for the treatment of NASH is cause for concern. To this end, the study evaluated Luo through a non-randomized open trial